KROS (STOCKS)
Keros Therapeutics, Inc. Common Stock
$10.660000
-0.540000 (-4.82%)
Prev close: $11.200000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jasbir S. Seehra
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $234.36M
- Employees
- 82
- P/E (TTM)
- -3.03
- P/B (TTM)
- 0.85
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-1.45 | $-1.37 | -0.0832 | -6.09% |
|
Mar 2026 (Q1)
|
$-1.21 | $-1.04 | -0.1667 | -15.98% |
|
Dec 2025 (Q4)
|
$-0.86 | $-0.64 | -0.2187 | -34.10% |
|
Sep 2025 (Q3)
|
$-0.18 | $-1.07 | +0.8879 | +83.14% |
Financial Statements
| Revenues | $14.54M |
| Benefits Costs and Expenses | $100.63M |
| Costs And Expenses | $100.63M |
| Nonoperating Income/Loss | $15.37M |
| Operating Expenses | $116.48M |
| Research and Development | $75.86M |
| Other Operating Expenses | $40.62M |
| Operating Income/Loss | -$101.47M |
| Income/Loss From Continuing Operations After Tax | -$83.16M |
| Income/Loss From Continuing Operations Before Tax | -$86.10M |
| Income Tax Expense/Benefit | -$2.94M |
| Net Income/Loss | -$83.16M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$83.16M |
| Net Income/Loss Available To Common Stockholders, Basic | -$83.16M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.22 |
| Diluted Earnings Per Share | -$3.22 |
| Basic Average Shares | 76,676,026 |
| Diluted Average Shares | 76,710,327 |
| Assets | $287.60M |
| Current Assets | $266.88M |
| Noncurrent Assets | $20.72M |
| Fixed Assets | $3.72M |
| Other Non-current Assets | $17.00M |
| Liabilities | $25.28M |
| Current Liabilities | $12.15M |
| Accounts Payable | $1.82M |
| Wages | $4.27M |
| Other Current Liabilities | $6.07M |
| Noncurrent Liabilities | $13.13M |
| Equity | $262.32M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $262.32M |
| Liabilities And Equity | $287.60M |
| Net Cash Flow From Operating Activities | -$47.99M |
| Net Cash Flow From Operating Activities, Continuing | -$47.99M |
| Net Cash Flow From Investing Activities | -$494.00K |
| Net Cash Flow From Investing Activities, Continuing | -$494.00K |
| Net Cash Flow From Financing Activities | -$384.12M |
| Net Cash Flow From Financing Activities, Continuing | -$384.12M |
| Net Cash Flow | -$432.61M |
| Net Cash Flow, Continuing | -$432.61M |
| Comprehensive Income/Loss | -$83.16M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$83.16M |
| Other Comprehensive Income/Loss | $0.00 |